etelcalcetide
Generic: ETELCALCETIDE·Brand: PARSABIV
etelcalcetide: 1 clinical trial tracked.
etelcalcetide evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about etelcalcetide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
Phase 3, Single-arm, Open-label, Multidose, Titration, Pharmacokinetic, Pharmacodynamic, and Safety Study of Etelcalcetide in Children and Adolescents ≥ 2 to < 18 Years of Age With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis
Primary endpoint: Percent Change From Baseline in iPTH at Weeks 20 to 26
Interventionalopen24 targetStarted 2019-12Completion 2027-0623 sites · Belgium, Czechia, France, Germany…Amgen